Skip to content
Research Article Open access CC BY 3.0

HBV Infection in Italian and Non-Italian Patients in Northern Italy

Massimo De Paschale, Maria Teresa Manco, Luisa Belvisi, Carlo Magnani, Tiziana Re, Paolo Viganò, Sara Biagiotti, Francesca Capelli, Antonino Mazzone, Maria Pia Baldacci, Aldo Ferrara, Anna Lisa Neri, Carlo Maria Guastoni, Riccardo Armando Bonazzina, Bruno Brando, Pierangelo Clerici

Journal of Advances in Medicine and Medical Research · pp. 1–12 · Published 8 Dec 2012

10.9734/BJMMR/2013/1981

Abstract

Aims: The introduction of HBV vaccination in Italy has reduced the incidence and prevalence of HBV infection. However, increasing immigration from countries in which HBV is endemic has led to a wave of new HBsAg-positive subjects and their clinical impact needs evaluation. We compared the serological, clinical and epidemiological data relating to Italian and non-Italian subjects referred to a hospital in Northern Italy. Study Design: We retrospectively analysed the laboratory and clinical records of 488 subjects, including 107 (21.9%) non-Italians, in order to find data concerning clinical diagnoses, possible routes of infection, anti-HCV and anti-HDV antibodies. Results: The differences in gender distribution and mean age between the non-Italian and Italian patients were statistically significant (p<.001). There were no significant differences in the prevalence of anti-HCV (2.9% vs 4.9%, p=.86) or anti-HDV (4.7% vs 5.0%, p=.89) co-infection, or the presence of HBeAg in chronic infection. There were no differences in the rates of acute (3.3% vs 5.1%; p=.68) or chronic infections (96.7% vs 94.9%; p=.68) infections, but there were statistically significant differences (p<.001) in the rates of prevalent (54.5% vs 85.3%) and incident cases (45.5% vs 14.7%). The differences in the rates of asymptomatic (70.6% vs 34.9%) and symptomatic patients (29.4% vs 65.1%) were also statistically significant (p<.001). The only significant differences in terms of risk factors related to transfusions (0% vs 6.8%; p=.04), and vertical/perinatal transmission (44.1% vs 6.8%; p<.001). Conclusion: The non-Italian HBsAg-positive subjects were mainly women and younger than their Italian counterparts, and had a recent diagnosis. They were predominantly asymptomatic and probably considered themselves healthy and fit to emigrate. Perinatal transmission among non-Italians is still an important risk factor that reflects the epidemiological situation of their countries of origin.

HBV Italy foreign origin hepatitis

References (37)

  1. 1 Management of Hepatocellular Carcinoma: An Update Δσ [DOI]
  2. 2 Hepatitis B Virus Infection [DOI]
  3. 3 Hepatitis B Virus Infection: Epidemiology and Vaccination [DOI]
  4. 4 A mathematical model to estimate global hepatitis B disease burden and vaccination impact [DOI]
  5. 5 Hepatitis B e antigen-negative chronic hepatitis B [DOI]
  6. 6 Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention [DOI]
  7. 7 Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease [DOI]
  8. 8 Hepatitis B viral genotypes: Clinical relevance and molecular characteristics [DOI]
  9. 9 World‐wide epidemiology of HBeAg‐negative chronic hepatitis B and associated precore and core promoter variants [DOI]
  10. 10 Classifying Hepatitis B Virus Genotypes [DOI]
  11. 11 What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy [DOI]
  12. 12 Treatment with Peg-Interferon alpha-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype [DOI]
  13. 13 Clinical significance of hepatitis B virus genotypes [DOI]
  14. 14 Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels [DOI]
  15. 15 Hepatitis B and hepatitis C [DOI]
  16. 16 The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy [DOI]
  17. 17 Acute Hepatitis B 14 Years after the Implementation of Universal Vaccination in Italy: Areas of Improvement and Emerging Challenges [DOI]
  18. 18 Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis [DOI]
  19. 19 Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study [DOI]
  20. 20 The changing pattern of hepatitis B virus infection over the past three decades in Italy [DOI]
  21. 21 Chronic Hepatitis B in Italy: New Features of an Old Disease--Approaching the Universal Prevalence of Hepatitis B e Antigen--Negative Cases and the Eradication of Hepatitis D Infection [DOI]
  22. 22 Vaccination against hepatitis B: the Italian strategy [DOI]
  23. 23 Hepatitis delta in Europe [DOI]
  24. 24 Prevalence of HBV genotypes in Central and Eastern Europe [DOI]
  25. 25 Hepatitis B virus genotypes: an overview.
  26. 26 Prevalence of Hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy [DOI]
  27. 27 Hepatitis B screening in the Turkish-Dutch population in Rotterdam, the Netherlands; qualitative assessment of socio-cultural determinants [DOI]
  28. 28 The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination [DOI]
  29. 29 Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North‐Eastern Italy [DOI]
  30. 30 PREVALENCE OF HEPATITIS B MARKERS IN ITALY [DOI]
  31. 31 MASS VACCINATION AGAINST HEPATITIS B IN INFANTS IN ITALY [DOI]
  32. 32 HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks.
  33. 33 Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: Clinical considerations and disease burden [DOI]
  34. 34 HBV Genotype and Clinical Outcome of Chronic Hepatitis B: Facts and Puzzles [DOI]
  35. 35 Epidemiology of viral hepatitis in Italy.
  36. 36 How immigration can change the prevalence of HBV infection in an urban area of Northern Italy [DOI]
  37. 37 Migration, Hepatitis B, and Hepatitis C [DOI]

Cited by 2

Applying the PDSA Framework to Examine the Use of the Clinical Nurse Leader to Evaluate Pressure Ulcer Reporting

Shea Polancich, Sarah Coiner, Rebekah Barber · Journal of Nursing Care Quality · 2017

The Process of Implementing a Mobility Technician in the General Medicine and Surgical Population to Increase Patient Mobility and Improve Hospital Quality Measures: A Pilot Study

Emelia Exum, Brian L. Hull · Journal of Acute Care Physical Therapy · 2019

Related research

Article metrics

Real usage data collected on this platform.

8

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.